Given that high TMB and PD-L1 overexpression are predictive biomarkers for immunotherapy [20], we suggest that, although very rare, patients with BAT26-only instability cancer need further tests for TMB and PD-L1 and would be a good candidate for immunotherapy. Here, CD274 is linked to cancer.